Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-24-021072
Filing Date
2024-12-27
Accepted
2024-12-27 17:15:16
Documents
4
Period of Report
2024-12-27

Document Format Files

Seq Description Document Type Size
1 w12192426k.htm 6-K 15492
2 EXHIBIT 1.1 ex1_1.htm EX-1.1 643568
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 94909
4 GRAPHIC brownrudnick_logo.jpg GRAPHIC 6476
  Complete submission text file 0001214659-24-021072.txt   764211
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 241586321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)